Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Citi
Express Scripts
Chubb
Chinese Patent Office
McKinsey
UBS
QuintilesIMS
Julphar
Accenture
Johnson and Johnson

Generated: October 17, 2017

DrugPatentWatch Database Preview

ARIMIDEX Drug Profile

« Back to Dashboard

What is the patent landscape for Arimidex, and when can generic versions of Arimidex launch?

Arimidex is a drug marketed by Astrazeneca Pharms and is included in one NDA.

The generic ingredient in ARIMIDEX is anastrozole. There are twenty-four drug master file entries for this compound. Thirty-four suppliers are listed for this compound. Additional details are available on the anastrozole profile page.

Summary for Tradename: ARIMIDEX

US Patents:0
Applicants:1
NDAs:1
Suppliers / Packagers: see list2
Bulk Api Vendors: see list86
Clinical Trials: see list70
Patent Applications: see list7,084
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:ARIMIDEX at DailyMed

Pharmacology for Tradename: ARIMIDEX

Drug ClassAromatase Inhibitor
Mechanism of ActionAromatase Inhibitors
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Astrazeneca Pharms
ARIMIDEX
anastrozole
TABLET;ORAL020541-001Dec 27, 1995ABRXYesYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: ARIMIDEX

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Astrazeneca Pharms
ARIMIDEX
anastrozole
TABLET;ORAL020541-001Dec 27, 1995► Subscribe► Subscribe
Astrazeneca Pharms
ARIMIDEX
anastrozole
TABLET;ORAL020541-001Dec 27, 1995► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Fuji
Daiichi Sankyo
Federal Trade Commission
McKinsey
Covington
Harvard Business School
US Department of Justice
Fish and Richardson
Colorcon
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot